216 related articles for article (PubMed ID: 38113333)
1. RHOA
Schaefer A; Hodge RG; Zhang H; Hobbs GA; Dilly J; Huynh MV; Goodwin CM; Zhang F; Diehl JN; Pierobon M; Baldelli E; Javaid S; Guthrie K; Rashid NU; Petricoin EF; Cox AD; Hahn WC; Aguirre AJ; Bass AJ; Der CJ
Sci Signal; 2023 Dec; 16(816):eadg5289. PubMed ID: 38113333
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-Function
Zhang H; Schaefer A; Wang Y; Hodge RG; Blake DR; Diehl JN; Papageorge AG; Stachler MD; Liao J; Zhou J; Wu Z; Akarca FG; de Klerk LK; Derks S; Pierobon M; Hoadley KA; Wang TC; Church G; Wong KK; Petricoin EF; Cox AD; Lowy DR; Der CJ; Bass AJ
Cancer Discov; 2020 Feb; 10(2):288-305. PubMed ID: 31771969
[TBL] [Abstract][Full Text] [Related]
3. RHOA drivers take alternate routes in gastric cancer.
Benton D; Chernoff J
Sci Signal; 2023 Dec; 16(816):eadk9171. PubMed ID: 38113334
[TBL] [Abstract][Full Text] [Related]
4. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
[TBL] [Abstract][Full Text] [Related]
5. In vivo effects of mutant RHOA on tumor formation in an orthotopic inoculation model.
Nishizawa T; Nakano K; Fujii E; Komura D; Kuroiwa Y; Ishimaru C; Monnai M; Aburatani H; Ishikawa S; Suzuki M
Oncol Rep; 2019 Nov; 42(5):1745-1754. PubMed ID: 31485674
[TBL] [Abstract][Full Text] [Related]
6. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?
Hodge RG; Schaefer A; Howard SV; Der CJ
Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):386-407. PubMed ID: 32838579
[TBL] [Abstract][Full Text] [Related]
7. RhoA G17E/Vav1 Signaling Induces Cancer Invasion via Matrix Metalloproteinase-9 in Gastric Cancer.
Nakamura S; Kitazawa M; Miyagawa Y; Koyama M; Miyazaki S; Hondo N; Muranaka F; Tokumaru S; Yamamoto Y; Ehara T; Matsumura T; Takeoka M; Soejima Y
Technol Cancer Res Treat; 2023; 22():15330338221146024. PubMed ID: 36617975
[TBL] [Abstract][Full Text] [Related]
8. A New Rho(d) Map to Diffuse Gastric Cancer.
Benton D; Chernoff J
Cancer Discov; 2020 Feb; 10(2):182-184. PubMed ID: 32024682
[TBL] [Abstract][Full Text] [Related]
9. Aberrant alternative splicing of RHOA is associated with loss of its expression and activity in diffuse-type gastric carcinoma cells.
Miyamoto S; Nagamura Y; Nakabo A; Okabe A; Yanagihara K; Fukami K; Sakai R; Yamaguchi H
Biochem Biophys Res Commun; 2018 Jan; 495(2):1942-1947. PubMed ID: 29247652
[TBL] [Abstract][Full Text] [Related]
10. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma.
Kakiuchi M; Nishizawa T; Ueda H; Gotoh K; Tanaka A; Hayashi A; Yamamoto S; Tatsuno K; Katoh H; Watanabe Y; Ichimura T; Ushiku T; Funahashi S; Tateishi K; Wada I; Shimizu N; Nomura S; Koike K; Seto Y; Fukayama M; Aburatani H; Ishikawa S
Nat Genet; 2014 Jun; 46(6):583-7. PubMed ID: 24816255
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics of RHOA mutations in a Central European gastric cancer cohort.
Röcken C; Behrens HM; Böger C; Krüger S
J Clin Pathol; 2016 Jan; 69(1):70-5. PubMed ID: 26251521
[TBL] [Abstract][Full Text] [Related]
12. ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer.
Komatsu M; Ichikawa H; Chiwaki F; Sakamoto H; Komatsuzaki R; Asaumi M; Tsunoyama K; Fukagawa T; Matsushita H; Boku N; Matsusaki K; Takeshita F; Yoshida T; Sasaki H
Oncogene; 2022 Oct; 41(43):4779-4794. PubMed ID: 36127398
[TBL] [Abstract][Full Text] [Related]
13. Rho guanosine 5'-triphosphatases differentially regulate insulin-like growth factor I (IGF-I) receptor-dependent and -independent actions of IGF-II on human trophoblast migration.
Shields SK; Nicola C; Chakraborty C
Endocrinology; 2007 Oct; 148(10):4906-17. PubMed ID: 17640993
[TBL] [Abstract][Full Text] [Related]
14. c-Met-dependent phosphorylation of RhoA plays a key role in gastric cancer tumorigenesis.
Liu J; Li S; Chen S; Chen S; Geng Q; Xu D
J Pathol; 2019 Sep; 249(1):126-136. PubMed ID: 31056743
[TBL] [Abstract][Full Text] [Related]
15. Integrin engagement differentially modulates epithelial cell motility by RhoA/ROCK and PAK1.
Zhou H; Kramer RH
J Biol Chem; 2005 Mar; 280(11):10624-35. PubMed ID: 15611088
[TBL] [Abstract][Full Text] [Related]
16. DGC-specific
Nishizawa T; Nakano K; Harada A; Kakiuchi M; Funahashi SI; Suzuki M; Ishikawa S; Aburatani H
Oncotarget; 2018 May; 9(33):23198-23207. PubMed ID: 29796182
[No Abstract] [Full Text] [Related]
17. Regulation of RhoA GTP hydrolysis by the GTPase-activating proteins p190, p50RhoGAP, Bcr, and 3BP-1.
Zhang B; Zheng Y
Biochemistry; 1998 Apr; 37(15):5249-57. PubMed ID: 9548756
[TBL] [Abstract][Full Text] [Related]
18. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.
Liu BP; Burridge K
Mol Cell Biol; 2000 Oct; 20(19):7160-9. PubMed ID: 10982832
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic mutations on Rac1 affect global intrinsic dynamics underlying GTP and PAK1 binding.
Acuner SE; Sumbul F; Torun H; Haliloglu T
Biophys J; 2021 Mar; 120(5):866-876. PubMed ID: 33515600
[TBL] [Abstract][Full Text] [Related]
20. Interaction of Rac1 with GTPase-activating proteins and putative effectors. A comparison with Cdc42 and RhoA.
Zhang B; Chernoff J; Zheng Y
J Biol Chem; 1998 Apr; 273(15):8776-82. PubMed ID: 9535855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
